Drug Discovery World

AUGUST 12, 2022

Pfizer has launched a Phase III clinical trial of a vaccine to protect people against Lyme disease, in collaboration with pharmaceutical company Valneva. . The trial will enrol up to 6,000 participants aged five years and older and will be conducted across 50 sites where Lyme disease is highly endemic. February 2022.

Vaccine 130

Vaccine Disease Trials Pharmaceutical Companies 130

Drug Discovery World

DECEMBER 9, 2022

A new type of targeted medicine has shown ‘remarkable’ benefits for patients with advanced breast cancer in a major Phase III clinical trial. . It was discovered by pharmaceutical company AstraZeneca following a programme of drug discovery research at The Institute of Cancer Research, London. . The CAPItello-291 trial.

Trials 130

Trials Therapies Drugs Treatment 130

PPD

AUGUST 16, 2023

The COVID-19 pandemic rapidly accelerated the adoption of hybrid and decentralized clinical trial (DCT) models. However, as the world settles into its post-pandemic state and returns to pre-pandemic paradigms in many areas, the pharmaceutical industry remains dedicated to moving beyond traditional, centralized clinical trial constructs.

Clinical Trials 98

Clinical Trials Trials Clinical Research FDA 98

H1 Blog

DECEMBER 4, 2023

As the pharmaceutical and biotech industries continue to push for faster drug development, the importance of equity and diversity in clinical trial recruitment cannot be overlooked. Data is a powerful tool in identifying and reaching vulnerable populations for clinical trials.

Clinical Trials 59

Clinical Trials Trials Pharmaceutical Companies Pharmaceuticals 59

Drug Discovery World

JANUARY 23, 2024

Solving bottlenecks in precision medicine R&D Medical trials underpin modern healthcare yet clinical research is an incredibly complex and time-consuming process for both patients and companies running trials, including pharmaceutical companies and emerging biotech startups.

Clinical Trials 130

Clinical Trials Pharmaceutical Companies Trials Drug Development 130

Drug Discovery World

JULY 11, 2024

Over the last year Closed Loop Medicine has published clinical trial data validating use of its technology for personalised treatment of hypertension, and entered several partnerships with pharmaceutical companies.

Pharmaceutical Companies 147

Pharmaceutical Companies Clinical Trials Engineering Treatment 147

Antidote

JANUARY 3, 2024

While the primary goal of clinical trials is to help identify potential new treatments that improve people's health and save lives, it's the unfortunate truth that the patient experience is often not prioritized.

Clinical Trials 52

Clinical Trials Trials Pharmaceutical Companies Pharmaceuticals 52

Drug Discovery World

SEPTEMBER 26, 2022

It’s why pharmaceutical companies will often spend up to 10 years and upwards of $1 billion before receiving regulatory approval for a drug. This is a stark contrast to the often decade-long projects that pharmaceutical companies undertake to bring a drug to market.

Pharmaceutical Companies 130

Pharmaceutical Companies Drugs Pharmaceuticals Clinical Trials 130

Drug Discovery World

MARCH 14, 2024

Pharmaceutical company Promontory Therapeutics has completed enrolment of its Phase II clinical trial of lead therapeutic candidate, PT-112, in patients with late-line metastatic castration-resistant prostate cancer (mCRPC).

Clinical Trials 130

Clinical Trials Pharmaceutical Companies Drugs FDA 130

Drug Discovery World

JANUARY 29, 2024

Utilising diverse data in clinical trials for drug discovery: Key speakers from pharma and industry discussed the integration of diverse data in clinical trials, emphasising its role in accelerating drug discovery processes for more effective and personalised treatments.

Clinical Trials 147

Clinical Trials Pharmaceutical Companies Trials Pharmaceuticals 147

Vial

JUNE 24, 2024

Contract research organizations (CROs) and pharmaceutical companies can leverage these cutting-edge technologies to streamline clinical trials and introduce automation in drug discovery. As clinical trials grow in complexity, the volume of data being gathered and utilized for these studies is expanding.

Clinical Trials 52

Clinical Trials Trials Clinical Research Regulations 52

Drug Discovery World

NOVEMBER 29, 2023

The simulator could also be used by pharmaceutical companies to rapidly test multiple drug therapies and patient scenarios, increasing the speed and cost of drug development. These findings closely matched the results of the corresponding real-life clinical trials.

Drug Development 130

Drug Development Pharmaceutical Companies Drugs FDA Approval 130

Drug Discovery World

JUNE 2, 2023

AI-designed monoclonal antibody ‘redirects’ the immune system Immuno-oncology company Aulos Bioscience has revealed interim results from an ongoing Phase I/II trial of monoclonal antibody AU-007 in solid tumours.

Pharmaceutical Companies 130

Pharmaceutical Companies Clinical Trials Drugs Pharmaceuticals 130

Drug Discovery World

MAY 6, 2024

Europe is traditionally a life sciences powerhouse, with a strong tradition in pharmaceutical discovery. The oldest, still active pharmaceutical company worldwide, Merck, started life in 1668 in Darmstadt, Germany. Members of the European Federation of Pharmaceutical Industries and Associations (EFPIA) spent €41.5

Drugs 147

Drugs Science Molecular Biology Clinical Trials 147

Drug Discovery World

NOVEMBER 11, 2022

Seven pharmaceutical companies have announced a joint initiative to reduce near-term emissions and help develop net zero health systems. . The Task Force will now take collective action to address emissions across three priority areas: supply chains, patient care pathways and clinical trials. Three areas of priority .

Pharma Companies 239

Pharma Companies Clinical Trials Government Trials 239

Drug Discovery World

APRIL 17, 2024

The Bios Innovation Circle is a venture studio and strategic hub designed to catalyse the growth of start-ups, growing biotech and life science companies in a cost-effective and equity-sparing manner.

Science 130

Science Pharmaceutical Companies Clinical Research Therapies 130

H1 Blog

DECEMBER 18, 2023

How will AI impact clinical trials? Every year, we take a look at annual predictions to help life sciences, pharmaceutical, and healthcare companies understand larger industry trends and dynamics to prepare for the new year. Will FDA legislation improve diversity? What platforms will key opinion leaders adopt?

Trials 64

Trials Clinical Trials FDA Pharmaceutical Companies 64

Drug Discovery World

FEBRUARY 1, 2023

Acquisition of UK innovation by US companies increased, including Pfizer’s acquisition of ReViral for an estimated £420 million, Gilead’s acquisition of MiroBio for an estimated £305 million, and Abbvie’s acquisition of DJS Antibodies for £229 million. Leading UK biotechs also achieved pivotal milestones in their development.

Pharmaceutical Companies 244

Pharmaceutical Companies Science Marketing Pharmaceuticals 244

DS in Pharmatics

SEPTEMBER 25, 2023

A robust Quality Management System (QMS) is an important aspect of a Pharmaceutical company as it demonstrates a company’s Senior Management commitment to Quality. QMS instills the mindset that assures that the company will have qualified and trained individuals who focus on “Quality” throughout the lifecycle of the product.

Clinical Trials 52

Clinical Trials Production Pharmaceutical Companies Trials 52

Drug Discovery World

AUGUST 12, 2022

New insights into melanoma, a company transition into life sciences and a Lyme disease vaccine are some of the stories in this week’s news round-up. Pfizer launches Phase III trial for Lyme disease vaccine?? . Life sciences company PerkinElmer will divest its?Applied, billion. .

Vaccine 130

Vaccine Pharmaceutical Companies Clinical Trials Drugs 130

Drug Discovery World

FEBRUARY 21, 2024

In October 2023, pharmaceutical company NKGen Biotech released data from its Phase I clinical trial on the use of its investigational natural killer therapy, SNK01, to treat patients with Alzheimer’s disease. RA: How encouraged are you by these Phase I data? RA: You’ve now received clearance for a Phase I/IIa study.

Therapies 306

Therapies Treatment Trials Disease 306

Drug Discovery World

MAY 3, 2023

Vicore Pharma, a Swedish clinical-stage pharmaceutical company unlocking the potential of angiotensin II type 2 receptor agonists (ATRAGs), has dosed its first patient with C21 in a clinical study of endothelial dysfunction. Vicore Pharma states that results from the trial are expected in Q4, 2023.

FDA Approval 130

FDA Approval Trials Pharmaceutical Companies Disease 130

Drug Discovery World

APRIL 25, 2023

We will continue to invest behind our pipeline and recent launches while continuing to improve profitability.

Pharmaceutical Companies 245

Pharmaceutical Companies Marketing Trials Treatment 245

DrugBank

MARCH 7, 2024

Pharmaceutical researchers, in particular, have a keen interest in understanding the unfolding dynamics of this market. Inspired by its success, pharmaceutical companies are pursuing the development of drugs with similar therapeutic profiles, aiming to expand treatment options.

Pharmaceutical Companies 80

Pharmaceutical Companies Pharmaceuticals Clinical Trials Pharmacokinetics 80

Drug Discovery World

APRIL 14, 2023

The pharmaceutical firm also provided promising updates on mRNA-4157/V940, which targets different tumour types, at Moderna’s Vaccines Day on 24 March 2023. The study found that participants given the treatment, AXA1125, developed by US pharmaceutical company Axcella Therapeutics, felt less fatigued than those given a placebo.

Vaccine 130

Vaccine Clinical Trials Drugs Pharmaceutical Companies 130

Drug Channels

FEBRUARY 7, 2024

Tomorrow, we’ll be treated to a Senate show trial featuring pharmaceutical company executives. In reality, nearly all drug spending growth occurred due to growth in the number of people treated, prescriptions dispensed, and other nonprice factors. healthcare expenditures.

Pharmaceutical Companies 98

Pharmaceutical Companies Drugs Pharmaceuticals Trials 98

Drug Discovery World

OCTOBER 20, 2022

Aqemia’s ‘innovation engine’, the Launchpad, has proven successful in several disclosed and undisclosed collaborations worth up to millions of euros with pharmaceutical companies such as Sanofi, Janssen and Servier.

Pharmaceutical Companies 130

Pharmaceutical Companies Drugs Engineering Clinical Trials 130

Drug Discovery World

NOVEMBER 11, 2022

BioSenic’s arsenic trioxide (ATO) autoimmune disease platform has completed a successful Phase IIb trial in chronic Graft vs Host Disease (cGVHD) and is preparing to move to a Phase III trial. . Pharma companies team-up to reduce emissions .

Pharma Companies 130

Pharma Companies Drugs Pharmaceutical Companies Disease 130

Drug Discovery World

MARCH 2, 2023

” The role of AI in rare disease clinical trials might hold the key to helping the UK achieve this vision. AI is revolutionising clinical trials and drug developments just as it is transforming other sectors, but in order for AI to make progress in rare diseases, the UK needs further investment to increase uptake and use.

Drug Development 130

Drug Development Disease Clinical Trials Drugs 130

PPD

APRIL 30, 2024

31, 2022, the EU Clinical Trial Regulation (EU CTR) 536/2014 became applicable, heralding a new era for clinical trials in the European Union (EU). In addition, the constant evolution of EMA and Clinical Trials Coordination Group (CTCG) guidelines requires constant attention.

Clinical Trials 52

Clinical Trials Regulations Trials Pharmaceutical Companies 52

The Pharma Data

SEPTEMBER 15, 2020

Biopharma and pharmaceutical companies developing treatments and vaccines have long faced operational challenges that cost time and money while draining resources from the important work of changing lives. Working closely with researchers, Avantor quickly developed a solution that incorporated customized kits for the clinical trial.

Clinical Trials 52

Clinical Trials Trials Pharmaceutical Companies Vaccine 52

Quanticate

SEPTEMBER 27, 2024

Each scientific field whether it be oncology , dermatology , rare disease , or others, presents unique challenges and opportunities that are crucial to improving patient outcomes, as well as guiding the efforts of researchers, physicians, and pharmaceutical companies in advancing healthcare solutions globally.

Clinical Research 52

Clinical Research Research Pharmaceutical Companies Science 52

Drug Discovery World

JULY 5, 2023

MG: Agilent works as closely as we can with the researchers, clinicians, and pharmaceutical companies that are at the forefront of developing therapeutic strategies to understand what they need from a technical point of view. RA: How is Agilent supporting cancer research?

Research 246

Research Immune Response Pharmaceutical Companies Treatment 246

BioPharma Drive: Drug Pricing

AUGUST 17, 2023

The German pharmaceutical company is launching three Phase 3 trials of an obesity drug called survodutide, which like Wegovy targets the GLP-1 receptor

Pharmaceutical Companies 52

Pharmaceutical Companies Pharmaceuticals Trials Drugs 52

Perficient: Drug Development

SEPTEMBER 10, 2024

Powering Patient-Centric Clinical Trials with AI and Data Explore how Life Sciences Cloud leverages AI to power comprehensive, customized, next-generation clinical trials for pharmaceutical companies. Gain insights into AI-driven solutions for optimizing clinical trials and enhancing customer experiences.

Science 52

Science Clinical Trials Pharmaceutical Companies Trials 52

Drug Discovery World

FEBRUARY 13, 2024

The attention on this tool brought further waves of interest into how AI could be deployed across the pharmaceutical and drug discovery sectors. Earlier this year, UK-based BenevolentAI reported disappointing results of its atopic dermatitis drug from a Phase II clinical trial.

Small Molecule 147

Small Molecule Drugs Therapies Pharmaceutical Companies 147

The Pharma Data

FEBRUARY 25, 2021

Takeda Provides Updates on Phase 1/2 Clinical Trials of Novavax’ and Moderna’s COVID-19 Vaccine Candidates in Japan. – Phase 1/2 immunogenicity and safety trials designed to include 200 healthy Japanese adults followed for 12 months after second vaccination. TAK-919 clinical trial. TAK-019 clinical trial.

Clinical Trials 52

Clinical Trials Trials Vaccine Pharmaceutical Companies 52